Skip to content

Clinical trials

Withdrawn Cholangiocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Status: Withdrawn Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20111
20122
20131
20142
20163
20172
20182
20202
20217
20221
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Kejing Biotechnology Co., Ltd.1
City of Hope Medical Center1
Emory University1
Fudan University1
Galectin Therapeutics Inc.1
Geneplus-Beijing Co. Ltd.1
Jiangsu HengRui Medicine Co., Ltd.1
Jordan Kharofa1
Kwang Hyuck Lee1
M.D. Anderson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma32
Pancreatic Neoplasms7
Carcinoma, Hepatocellular6
Breast Neoplasms4
Gallbladder Neoplasms4
Liver Neoplasms4
Lung Neoplasms4
Colorectal Neoplasms3
Neoplasm Metastasis3
Neoplasms3

Trials

Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.